Letter by Neugebauer et al. regarding article "Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial"
- PMID: 31530280
- PMCID: PMC6749710
- DOI: 10.1186/s13054-019-2600-9
Letter by Neugebauer et al. regarding article "Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial"
Keywords: Hemicraniectomy; Hypothermia; Stroke.
Conflict of interest statement
Dr. Neugebauer reported having financial affiliations with Boehringer Ingelheim, Bayer, and Daiichi-Sankyo.
Dr. Kollmar reported having financial affiliations with Boehringer Ingelheim, Bayer, Braincool, and Bard.
Dr. Schneider reported no competing interests.
Comment on
-
Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial.Crit Care. 2019 May 9;23(1):164. doi: 10.1186/s13054-019-2452-3. Crit Care. 2019. PMID: 31072354 Free PMC article. No abstract available.
References
-
- Neugebauer H, Schneider H, Bösel J, Hobohm C, Poli S, Kollmar R, et al. Outcomes of hypothermia in addition to decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial. JAMA Neurol. 2019;76:571–579. doi: 10.1001/jamaneurol.2018.4822. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
